Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases

Y. Teng, M. Q. Ren, R. Cheney, S. Sharma, J. K. Cowell

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background:The WASF3 protein is involved in cell movement and invasion, and to investigate its role in prostate cancer progression we studied the phenotypic effects of knockdown in primary tumors and cell lines.Methods:ShRNA was used to knockdown WASF3 function in prostate cell lines. Cell motility (scratch wound assay), anchorage independent growth and in vivo tumorigenicity and metastasis were then compared between knockdown and wild-type cells.Results:Increased levels of expression were seen in high-grade human prostate cancer and in the PC3 and DU145 cell lines. Inactivation of WASF3 using shRNAs reduced cell motility and invasion in these cells and reduced anchorage independent growth in vitro. The loss of motility was accompanied by an associated increase in stress fiber formation and focal adhesions. When injected subcutaneously into severe combined immunodeficiency (SCID) mice, tumor formation was significantly reduced for PC3 and DU145 cells with WASF3 knockdown and in vivo metastasis assays using tail vain injection showed a significant reduction for PC3 and DU145 cells. The loss of the invasion phenotype was accompanied by down-regulation of matrix metalloproteinase 9.Conclusions: Overall, these observations demonstrate a critical role for WASF3 in the progression of prostate cancer and identify a potential target to control tumorigenicity and metastasis.

Original languageEnglish (US)
Pages (from-to)1066-1075
Number of pages10
JournalBritish Journal of Cancer
Volume103
Issue number7
DOIs
StatePublished - Sep 28 2010

Fingerprint

Gene Silencing
Prostatic Neoplasms
Neoplasm Metastasis
Cell Movement
Wiskott-Aldrich Syndrome Protein Family
Cell Line
Severe Combined Immunodeficiency
Stress Fibers
Focal Adhesions
Matrix Metalloproteinase 9
Growth
Tumor Cell Line
Tail
Prostate
Down-Regulation
Phenotype
Injections
Wounds and Injuries
Neoplasms

Keywords

  • MMP
  • WASF3
  • in vivo models
  • metastasis
  • prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. / Teng, Y.; Ren, M. Q.; Cheney, R.; Sharma, S.; Cowell, J. K.

In: British Journal of Cancer, Vol. 103, No. 7, 28.09.2010, p. 1066-1075.

Research output: Contribution to journalArticle

@article{c7df1830869a493c8bd6348d7da01926,
title = "Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases",
abstract = "Background:The WASF3 protein is involved in cell movement and invasion, and to investigate its role in prostate cancer progression we studied the phenotypic effects of knockdown in primary tumors and cell lines.Methods:ShRNA was used to knockdown WASF3 function in prostate cell lines. Cell motility (scratch wound assay), anchorage independent growth and in vivo tumorigenicity and metastasis were then compared between knockdown and wild-type cells.Results:Increased levels of expression were seen in high-grade human prostate cancer and in the PC3 and DU145 cell lines. Inactivation of WASF3 using shRNAs reduced cell motility and invasion in these cells and reduced anchorage independent growth in vitro. The loss of motility was accompanied by an associated increase in stress fiber formation and focal adhesions. When injected subcutaneously into severe combined immunodeficiency (SCID) mice, tumor formation was significantly reduced for PC3 and DU145 cells with WASF3 knockdown and in vivo metastasis assays using tail vain injection showed a significant reduction for PC3 and DU145 cells. The loss of the invasion phenotype was accompanied by down-regulation of matrix metalloproteinase 9.Conclusions: Overall, these observations demonstrate a critical role for WASF3 in the progression of prostate cancer and identify a potential target to control tumorigenicity and metastasis.",
keywords = "MMP, WASF3, in vivo models, metastasis, prostate cancer",
author = "Y. Teng and Ren, {M. Q.} and R. Cheney and S. Sharma and Cowell, {J. K.}",
year = "2010",
month = "9",
day = "28",
doi = "10.1038/sj.bjc.6605850",
language = "English (US)",
volume = "103",
pages = "1066--1075",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases

AU - Teng, Y.

AU - Ren, M. Q.

AU - Cheney, R.

AU - Sharma, S.

AU - Cowell, J. K.

PY - 2010/9/28

Y1 - 2010/9/28

N2 - Background:The WASF3 protein is involved in cell movement and invasion, and to investigate its role in prostate cancer progression we studied the phenotypic effects of knockdown in primary tumors and cell lines.Methods:ShRNA was used to knockdown WASF3 function in prostate cell lines. Cell motility (scratch wound assay), anchorage independent growth and in vivo tumorigenicity and metastasis were then compared between knockdown and wild-type cells.Results:Increased levels of expression were seen in high-grade human prostate cancer and in the PC3 and DU145 cell lines. Inactivation of WASF3 using shRNAs reduced cell motility and invasion in these cells and reduced anchorage independent growth in vitro. The loss of motility was accompanied by an associated increase in stress fiber formation and focal adhesions. When injected subcutaneously into severe combined immunodeficiency (SCID) mice, tumor formation was significantly reduced for PC3 and DU145 cells with WASF3 knockdown and in vivo metastasis assays using tail vain injection showed a significant reduction for PC3 and DU145 cells. The loss of the invasion phenotype was accompanied by down-regulation of matrix metalloproteinase 9.Conclusions: Overall, these observations demonstrate a critical role for WASF3 in the progression of prostate cancer and identify a potential target to control tumorigenicity and metastasis.

AB - Background:The WASF3 protein is involved in cell movement and invasion, and to investigate its role in prostate cancer progression we studied the phenotypic effects of knockdown in primary tumors and cell lines.Methods:ShRNA was used to knockdown WASF3 function in prostate cell lines. Cell motility (scratch wound assay), anchorage independent growth and in vivo tumorigenicity and metastasis were then compared between knockdown and wild-type cells.Results:Increased levels of expression were seen in high-grade human prostate cancer and in the PC3 and DU145 cell lines. Inactivation of WASF3 using shRNAs reduced cell motility and invasion in these cells and reduced anchorage independent growth in vitro. The loss of motility was accompanied by an associated increase in stress fiber formation and focal adhesions. When injected subcutaneously into severe combined immunodeficiency (SCID) mice, tumor formation was significantly reduced for PC3 and DU145 cells with WASF3 knockdown and in vivo metastasis assays using tail vain injection showed a significant reduction for PC3 and DU145 cells. The loss of the invasion phenotype was accompanied by down-regulation of matrix metalloproteinase 9.Conclusions: Overall, these observations demonstrate a critical role for WASF3 in the progression of prostate cancer and identify a potential target to control tumorigenicity and metastasis.

KW - MMP

KW - WASF3

KW - in vivo models

KW - metastasis

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=77957239866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957239866&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6605850

DO - 10.1038/sj.bjc.6605850

M3 - Article

C2 - 20717117

AN - SCOPUS:77957239866

VL - 103

SP - 1066

EP - 1075

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 7

ER -